Use of intravenous γ-globulin for Kawasaki disease: Effects on cardiac sequelae

Pediatric Cardiology

Volumn 18, Issue 1, 1997, Pages 19-23

  Yanagawa, H ^a   Nakamura, Y ^a   Sakata, K ^a   Yashiro, M ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac sequelae; Gamma globulin treatment; Kawasaki disease

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CHILD; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; IMMUNOTHERAPY; INFANT; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRACTICE GUIDELINE; PREVALENCE; VALVULAR HEART DISEASE;

CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INJECTIONS, INTRAVENOUS; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREVALENCE; QUESTIONNAIRES;

EID: 0031060588     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002469900102     Document Type: Article

References (12)

1. Furusho K, Kamiya T, Nakano H, et al. (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055-1058
2. Harada K (1991) Intravenous gammaglobulin treatment in Kawasaki disease. Acta Paedicitr Jpn 33:805-810
3. Japan Kawasaki Disease Research Committee (1984) Diagnostic Guidelines of Kawasaki Disease, 4th rev. ed. Tokyo
4. Matsushima M, Nagashima M, Matsuoka H, et al. (1986) Controlled study on high dose gammaglobulin treatment for Kawasaki disease. Report 1. gammaglobulin administration of 400 mg/kg for 5 days. Nippon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 90:80-87 (in Japanese)
5. Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumura M (1987) High-dose gammaglobulin therapy for Kawasaki disease. J Pediatr 110:710-712
6. Newburger JW, Takahashi M, Beiser AS, et al. (1991) A single intravenous infusion of gamma globulin compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
7. Newburger JW, Takahashi M, Burns JC, et al. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
8. Ogawa M, Ogino H, Hurima Y, et al. (1987) Evaluation of gammaglobulin treatment for Kawasaki disease: efficacy of the administration of the dose of 400 mg/kg for 3 days. Nippon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 91:3763-3771 (in Japanese)
9. Ogino H, Ogawa M, Harima Y, et al. (1987) Evaluation of gammaglobulin treatment for Kawasaki disease: efficacy of the administration of the dose of 200 mg/kg for 3 days. Nippon Shonika Gakkai Zasshi (Jpn Pediatr Soc) 91:2849-2856 (in Japanese)
10. Onouchi Z, Yanagisawa M, Shiraishi H, et al. (1992) Multicenter randomized controlled study of intravenous immunoglobulin G(C-425) for Kawasaki disease. 1. Study for optimal dosage and usefulness of C-425. Nippon Shonika Gakkai Zasshi (Jpn Pediatr Soc) 96:2669-2679 (in Japanese)
11. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H (1995) Epidemiological pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 95:475-479
12. Yanagawa H, Yashiro M, Nakumura Y, Kawasaki T, Kato H (1995) Results of twelve nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediutr Adolesc Med 149:779-783